![]() |
市场调查报告书
商品编码
1953473
光学同调断层扫描市场-全球产业规模、份额、趋势、机会及预测(按类型、技术、应用、地区和竞争格局划分,2021-2031年)Optical Coherence Tomography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Application, By Region & Competition, 2021-2031F |
||||||
全球光同调断层扫瞄(OCT)市场预计将从 2025 年的 18.8 亿美元成长到 2031 年的 28.7 亿美元,复合年增长率为 7.31%。
光学相干断层扫描(OCT)是一种非侵入性诊断工具,它利用低相干干涉技术产生生物组织的高解析度截面影像,主要用于视网膜评估和冠状动脉血管分析。市场成长趋势主要受全球人口快速老化以及由此导致的慢性眼科疾病(如老龄化黄斑部病变和青光眼)发病率上升的推动,这些疾病需要频繁且高精度的监测。国际防盲机构(IAPB)2024年的数据也印证了对这种可扩展诊断技术日益增长的需求。该机构预测,未来30年视力丧失可能增加55%,凸显了先进影像诊断技术在预防失明方面的重要角色。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 18.8亿美元 |
| 市场规模:2031年 | 28.7亿美元 |
| 复合年增长率:2026-2031年 | 7.31% |
| 成长最快的细分市场 | 频域光学相干断层扫描(FD-OCT) |
| 最大的市场 | 北美洲 |
儘管临床需求强劲,但由于这些先进系统实施和维修成本高昂,市场面临许多障碍,阻碍了其在资源有限的医疗机构中的广泛应用。这种经济障碍有效地阻止了其在发展中地区和小规模独立诊所的市场渗透,因为这些诊所缺乏大型医院网路那样雄厚的资本预算。此外,操作OCT设备并解读其复杂数据需要专门的培训,这造成了人才短缺,可能会延缓这些设备融入日常诊疗流程,而高效的患者护理在这些流程中至关重要。
老龄化相关眼科疾病的日益普遍显着增加了临床对精准诊断影像的需求,成为全球光同调断层扫瞄)市场的主要驱动力。随着全球人口老化趋势的加剧,糖尿病视网膜病变和老龄化黄斑部病变等疾病的发生率显着上升,使得定期视网膜筛检和早期发现至关重要。疾病发生率的增加直接推动了基层医疗和专科眼科对OCT设备的需求。例如,Eyes On Eyecare于2024年5月发表的报导「模型估计值:糖尿病视网膜病变盛行率」的文章指出,目前约有四分之一的40岁及以上糖尿病患者患有糖尿病视网膜病变,凸显了需要定期进行OCT评估的患者数量庞大。
扫频源和频谱域光学相干断层扫描(OCT)技术的突破正在消除影像解析度、速度和组织渗透性方面的传统限制,进一步推动市场扩张。製造商正投入大量资源进行研发,以整合人工智慧(AI)和先进的视觉化功能,从而简化临床工作流程并提高诊断准确性。这种对创新的投入也体现在主要企业的财务策略中。例如,卡尔蔡司医疗技术股份公司(Carl Zeiss Meditec AG)于2024年12月发布的《2023/24年度报告》指出,该公司将16.6%的企业收入投入研发,以推动未来成长并保持技术优势。这些进步增强了临床效用,并促进了OCT技术的广泛普及。正如SpecsAvers于2024年10月发布的《2023-24年度回顾》所示,每年进行的OCT扫描超过770万次,证实了该技术在现代眼科中的关键作用。
光同调断层扫瞄)系统购买和维护所需的大量资本投入是全球市场成长的主要障碍。高昂的拥有成本实际上将开发中国家的小规模独立诊所和医疗机构拒之门外,使其无法使用这项技术,导致市场主要局限于资金雄厚的医院网络。当诊断中心面临严格的预算限制时,无论临床上对视网膜成像的需求如何,无力投资此类资本密集型设备都会直接降低製造商的潜在市场规模。
报销率的下降加剧了这一财务障碍,延长了这些设备的投资回收期,并阻碍了诊所升级设备的动机。例如,美国眼科学会2024年报告称,美国医疗保险和医疗补助服务中心决定将2025财年的医生收费标准转换係数降低约2.8%。营运收入的下降显着限制了眼科诊所的购买力,延缓了先进OCT系统的普及,最终减缓了市场整体扩张的步伐。
家用光学相干断层扫描(OCT)系统的兴起正在改变视网膜疾病的管理模式,使诊断不再依赖集中式医疗机构。这一趋势有助于对老龄化黄斑部病变等疾病进行常规监测,从而实现早期发现病变,而无需频繁就诊。近期,患者可控设备获得监管部门核准,进一步增强了该模式的临床可行性,减少了与诊所监测相关的后勤挑战。例如,NotalVision公司在2024年5月发布的题为「FDA授予NotalVision人工智慧家用OCT设备SCANLY新的上市核准」的新闻稿中指出,在一项关键性临床试验中,97%的参与者成功在家中采集了OCT影像,证实了自我成像是一种可靠的疾病进展追踪方法。
同时,市场正拓展至介入性心臟病学领域,血管内OCT在该领域展现出优于传统血管造影术的优势。这项技术能够提供血管形态的高解析度视觉化影像,使心臟病专家能够在复杂病例中精准定位支架,从而显着提高病患安全性。 OCT的精准度是传统影像技术无法企及的,这项临床优势正推动其在导管检查室的应用。欧洲心臟学会2024年9月发表的一篇题为「光学同调断层扫描血管造影术方面优于传统血管造影」的论文证实了这一优势。论文报告称,在OCCUPI试验中,与血管造影术引导的手术相比,OCT引导可将不利事件的综合风险降低38%。
The Global Optical Coherence Tomography Market is projected to expand from USD 1.88 Billion in 2025 to USD 2.87 Billion by 2031, registering a CAGR of 7.31%. As a non-invasive diagnostic tool, OCT employs low-coherence interferometry to generate high-resolution, cross-sectional images of biological tissues, primarily utilized for retinal assessments and coronary vascular analysis. The market's upward trajectory is largely fueled by a rapidly aging global demographic and a corresponding increase in chronic eye conditions like age-related macular degeneration and glaucoma, which require frequent, high-precision monitoring. This growing necessity for scalable diagnostics is underscored by data from the International Agency for the Prevention of Blindness in 2024, which forecasts a potential 55 percent rise in vision loss over the next three decades, emphasizing the vital role of advanced imaging in preventing blindness.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.88 Billion |
| Market Size 2031 | USD 2.87 Billion |
| CAGR 2026-2031 | 7.31% |
| Fastest Growing Segment | Frequency Domain OCT (FD-OCT) |
| Largest Market | North America |
Despite robust clinical demand, the market encounters significant hurdles due to the high costs of acquiring and maintaining these sophisticated systems, which curtails adoption in resource-limited healthcare environments. This financial obstacle effectively hinders market penetration within developing regions and smaller independent clinics that lack the substantial capital budgets found in major hospital networks. Additionally, the need for specialized training to operate OCT equipment and interpret complex data results in a workforce bottleneck, potentially delaying the integration of these devices into general practice workflows where efficient patient throughput is critical.
Market Driver
The rising prevalence of age-related ocular disorders acts as a major engine for the Global Optical Coherence Tomography Market, significantly increasing the clinical requirement for precise diagnostic imaging. With global demographics trending toward an older population, the incidence of conditions like diabetic retinopathy and age-related macular degeneration has intensified, necessitating routine retinal screening and early detection. This uptick in disease frequency directly boosts demand for OCT devices across both primary optometry and specialized ophthalmology sectors. For example, a May 2024 article by Eyes On Eyecare titled 'Modeled Estimates: Prevalence of Diabetic Retinopathy' notes that roughly one in four Americans aged 40 and older with diabetes currently suffers from diabetic retinopathy, highlighting the immense volume of patients needing regular tomographic evaluation.
Technological breakthroughs in Swept-Source and Spectral-Domain OCT are further propelling market expansion by resolving earlier constraints related to imaging resolution, speed, and tissue penetration. Manufacturers are dedicating substantial resources to research and development to incorporate artificial intelligence and advanced visualization features, which help streamline clinical workflows and enhance diagnostic precision. This dedication to innovation is reflected in the financial strategies of key industry players; for instance, Carl Zeiss Meditec AG's 'Annual Report 2023/24' from December 2024 reveals the company invested 16.6 percent of its revenue into R&D to foster future growth and technological distinction. Such advancements improve clinical utility and facilitate widespread adoption, as evidenced by Specsavers' 'Annual Review 2023-24' from October 2024, which reported over 7.7 million OCT scans performed during the year, confirming the technology's essential place in modern eye care.
Market Challenge
The significant capital expenditure needed to purchase and maintain Optical Coherence Tomography systems constitutes a major impediment to global market growth. High ownership costs effectively exclude smaller independent clinics and healthcare facilities in developing nations from accessing the technology, confining the market largely to well-endowed hospital networks. When diagnostic centers operate under strict budgetary constraints, their inability to invest in such capital-intensive equipment directly shrinks the Total Addressable Market for manufacturers, irrespective of the clinical need for retinal imaging.
This financial hurdle is intensified by falling reimbursement rates, which prolong the Return on Investment period for these devices and dissuade practice owners from upgrading their equipment. For example, the American Academy of Ophthalmology reported in 2024 that the Centers for Medicare & Medicaid Services finalized a reduction of roughly 2.8 percent in the physician fee schedule conversion factor for the 2025 calendar year. Such decreases in operational revenue severely limit the purchasing power of ophthalmology practices, forcing them to delay acquiring advanced OCT systems and thereby slowing the overall pace of market expansion.
Market Trends
The rise of home-based OCT systems is transforming retinal disease management by shifting diagnostic care away from centralized facilities. This trend facilitates daily monitoring of conditions such as neovascular age-related macular degeneration, enabling the early detection of pathology without the need for frequent office visits. The clinical viability of this model was reinforced by recent regulatory approvals for patient-operated devices, which mitigate the logistical challenges of in-office monitoring. Highlighting the practicality of these platforms, a May 2024 press release from Notal Vision titled 'FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization' reported that pivotal trials found 97 percent of participants successfully captured OCT images at home, establishing self-imaging as a dependable method for longitudinal disease tracking.
Concurrently, the market is extending into interventional cardiology, where intravascular OCT is demonstrating superiority over standard angiography. By offering high-resolution visualization of vessel morphology, this technology allows cardiologists to refine stent deployment in complex cases, leading to significantly improved patient safety. This clinical advantage is fueling adoption in catheterization laboratories by providing a level of precision that traditional imaging cannot achieve. Demonstrating this benefit, the European Society of Cardiology's September 2024 article 'Optical coherence tomography outperforms conventional angiography for stent guidance in complex cases' noted that the OCCUPI trial showed OCT guidance lowered the combined risk of adverse cardiovascular events by 38 percent compared to angiography-guided procedures.
Report Scope
In this report, the Global Optical Coherence Tomography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Optical Coherence Tomography Market.
Global Optical Coherence Tomography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: